David Shook insider trades
Open-market stock purchases and sales by David Shook, Chief Medical Officer at Lyell Immunopharma, Inc, from SEC Form 4 filings since Jan 13, 2023.
Open-market stock purchases and sales by David Shook, Chief Medical Officer at Lyell Immunopharma, Inc, from SEC Form 4 filings since Jan 13, 2023.